Brief report
Ultrasound biomicroscopy in uveitis-glaucoma- hyphema syndrome

https://doi.org/10.1016/S0002-9394(02)01386-7Get rights and content

Abstract

PURPOSE: To assess anterior segment anatomy in uveitis-glaucoma- hyphema syndrome.

DESIGN: Retrospective case series.

METHODS: Nine pseudophakic eyes (nine patients) with complete or incomplete uveitis-glaucoma-hyphema syndrome underwent ultrasound biomicroscopy.

RESULTS: Ultrasound biomicroscopy revealed intraocular lens malposition in each case. Of the eight eyes with posterior chamber intraocular lenses, haptics were in contact with the iris pigment epithelium (four eyes) or the pars plicata (three eyes) or prolapsed into the angle recess near a filtration bleb internal ostium (one eye). All other posterior chamber intraocular lens haptics were located in the ciliary sulcus with the exception of two in the capsular bag. Both haptics in the eye with the anterior chamber intraocular lens had eroded into the ciliary body.

CONCLUSION: By its ability to detect haptic position, ultrasound biomicroscopy can assist in elucidating the cause of uveitis-glaucoma-hyphema syndrome and in deciding on the course of treatment.

References (5)

There are more references available in the full text version of this article.

Cited by (53)

  • Intraocular Lens Complications: Decentration, Uveitis–Glaucoma–Hyphema Syndrome, Opacification, and Refractive Surprises

    2021, Ophthalmology
    Citation Excerpt :

    Old blood in the vitreous cavity can give a clue as to an episode of previous VH. Anterior segment imaging such as ultrasound biomicroscopy is helpful in determining IOL position and whether iris contact is present.40,41 Ultrasound biomicroscopy is particularly helpful in identifying haptic position.41

  • Uveitis-glaucoma-hyphema syndrome associated with recurrent vitreous hemorrhage

    2015, Archivos de la Sociedad Espanola de Oftalmologia
View all citing articles on Scopus

Supported in part by The New York Eye and Ear Infirmary Department of Ophthalmology Research Fund, New York, New York; and the Steven and Shelley Einhorn Research Fund of the New York Glaucoma Research Institute, New York, New York.

View full text